Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hauser

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Psychological Science|September 27, 2012
Most reported genetic associations with general intelligence are probably false positivesChristopher F Chabris, Benjamin M Hebert, Daniel J Benjamin, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 2, 2017
Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated CancerM H Diekstra, A Fritsch, F Kanefendt, et al.
Archives of Neurology|September 15, 2005
Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directionsE M Frohman, M Filippi, O Stuve, et al.
Nature Communications|October 9, 2023
GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimeticsShane C Wright, Aikaterini Motso, Stefania Koutsilieri, et al.
British Journal of Pharmacology|May 30, 2025
Biodiversity2Drugs-Renaissance of exploring nature-derived peptides for GPCR ligand discoveryChristian W Gruber, Isabel Beets, Pierre-Luc Boudreault, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2023
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic PhenotypesJosefine U Melchiorsen, Kimmie V Sørensen, Jette Bork-Jensen, et al.
Elife|March 18, 2022
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRsCharlotte Avet, Arturo Mancini, Billy Breton, et al.
Journal of Neurology|June 24, 2015
Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1Alleene V Strickland, Maria Schabhüttl, Hans Offenbacher, et al.
Journal of Environmental Radioactivity|June 8, 2006
Characterisation of submarine groundwater discharge offshore south-eastern SicilyP P Povinec, P K Aggarwal, A Aureli, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Psychological Science|September 27, 2012
Most reported genetic associations with general intelligence are probably false positivesChristopher F Chabris, Benjamin M Hebert, Daniel J Benjamin, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 2, 2017
Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated CancerM H Diekstra, A Fritsch, F Kanefendt, et al.
Archives of Neurology|September 15, 2005
Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directionsE M Frohman, M Filippi, O Stuve, et al.
Nature Communications|October 9, 2023
GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimeticsShane C Wright, Aikaterini Motso, Stefania Koutsilieri, et al.
British Journal of Pharmacology|May 30, 2025
Biodiversity2Drugs-Renaissance of exploring nature-derived peptides for GPCR ligand discoveryChristian W Gruber, Isabel Beets, Pierre-Luc Boudreault, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2023
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic PhenotypesJosefine U Melchiorsen, Kimmie V Sørensen, Jette Bork-Jensen, et al.
Elife|March 18, 2022
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRsCharlotte Avet, Arturo Mancini, Billy Breton, et al.
Journal of Neurology|June 24, 2015
Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1Alleene V Strickland, Maria Schabhüttl, Hans Offenbacher, et al.
Journal of Environmental Radioactivity|June 8, 2006
Characterisation of submarine groundwater discharge offshore south-eastern SicilyP P Povinec, P K Aggarwal, A Aureli, et al.
Pageof 20